SeaSpine Holdings Corp. (SPNE)

14.25
NASDAQ : Health Technology
Prev Close 13.98
Day Low/High 13.78 / 14.36
52 Wk Low/High 11.16 / 20.75
Avg Volume 90.20K
Exchange NASDAQ
Shares Outstanding 18.90M
Market Cap 264.19M
EPS -2.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

SeaSpine Holdings Corp Breaks Below 200-Day Moving Average - Notable For SPNE

SeaSpine Holdings Corp Breaks Below 200-Day Moving Average - Notable For SPNE

In trading on Thursday, shares of SeaSpine Holdings Corp crossed below their 200 day moving average of $15.08, changing hands as low as $14.54 per share. SeaSpine Holdings Corp shares are currently trading off about 6.3% on the day.

SPNE Makes Notable Cross Below Critical Moving Average

SPNE Makes Notable Cross Below Critical Moving Average

In trading on Thursday, shares of SeaSpine Holdings Corp crossed below their 200 day moving average of $14.54, changing hands as low as $14.39 per share. SeaSpine Holdings Corp shares are currently trading down about 1.8% on the day.

SeaSpine Holdings Becomes Oversold (SPNE)

SeaSpine Holdings Becomes Oversold (SPNE)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

SeaSpine Holdings Reaches Analyst Target Price

SeaSpine Holdings Reaches Analyst Target Price

In recent trading, shares of SeaSpine Holdings Corp have crossed above the average analyst 12-month target price of $17.00, changing hands for $17.75/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

5 Cheap Stocks Primed for a Summer Rally

5 Cheap Stocks Primed for a Summer Rally

It's time to get ready for summer with these top trading ideas. Get your notepad out.

SeaSpine Announces Preliminary Results For Third Quarter 2017

SeaSpine Announces Preliminary Results For Third Quarter 2017

Updates High End of Revenue Range Guidance for 2017

UPDATE -- SeaSpine Announces Launch Of Shoreline® Anterior Cervical Standalone System

UPDATE -- SeaSpine Announces Launch Of Shoreline® Anterior Cervical Standalone System

Latest Commercialization of Proprietary NanoMetalene® Surface Technology

SeaSpine Announces Launch Of Shoreline® Anterior Cervical Standalone System

SeaSpine Announces Launch Of Shoreline® Anterior Cervical Standalone System

Latest Commercialization of Proprietary NanoMetalene® Surface Technology

TheStreet Quant Rating: D (Sell)